Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.

"Treatment of Skin Disease is your definitive source for managing the complete range of dermatologic conditions you're likely to encounter in practice. This medical reference book boasts an intuitive and easy to use format that covers the full spectrum of options, equipping you with not only standard treatment strategies, but second- and third-line therapies for instances when other alternatives fail"--Publisher's website

This book presents the most common skin diseases of children, which account for more than 90% of the presenting cases. In each chapter, the differential diagnostic possibilities are shown in a table where the most important distinguishing features are summarized. Treatment is presented in considerable detail, reflecting the current literature as well as the clinical experience in two large German pediatric dermatology clinics. The scientific names of all recommended medications are given so that the book can be used by readers around the globe, rather than just those with access to European medications. Tips are included for the treating physician on how to best tailor the various therapy regimens and anticipate the course of the disease. Recent advances in dermatologic therapy including tacrolimus, pimecrolimus, and imiquimod are included. The appendix contains detailed practical information on the choice of an appropriate vehicle, as well as on antibiotics, antihistamines, and topical corticosteroids.

Autoimmune disorders of the skin remain an enigma for many clinicians and scientists not familiar with these mostly severe and chronic diseases. The book provides an overview and the latest information on the broad spectrum of cutaneous autoimmune disorders for clinicians, scientists and practitioners in dermatology, medicine, rheumatology, ENT, pediatrics and ophthalmology. The book is unique since it presents the state-of-the-art knowledge on pathophysiology, clinical diagnosis and management of these disorders provided by the world experts in the field. The primary intention is to broaden the understanding of the pathophysiology of cutaneous autoimmune disorders and to provide a practical guide to how to identify and handle these conditions. The book is illustrated with many tables, illustrative figures and clinical color photographs. The third edition has been thoroughly updated and extended by chapters on paraneoplastic cutaneous syndromes, atopic dermatitis and autoimmunity and Skin manifestations of rheumatic diseases.

Now in a fully revised thirteenth edition, Andrews' Diseases of the Skin remains your single-volume, must-have resource for core information in dermatology. From residency through clinical practice, this award-winning title ensures that you stay up to date with new tools and strategies for diagnosis and treatment, new entities and newly recognized diseases, and current uses for tried-and-true and newer medications. It's the reference you'll turn to again and again when faced with a clinical conundrum or therapeutically challenging skin disease. - Utilizes a concise, clinically focused, user-friendly format that clearly covers the full range of common and rare skin diseases. - Provides outstanding visual support with 1,340 illustrations – more than 500 new to this edition. - Presents comprehensively updated information throughout, including new and unusual clinical presentations of syphilis, new diagnostic classifications and therapies for vascular anomalies, and an updated pediatric and genodermatosis review. - Covers new and evolving treatments for inflammatory, neoplastic, and blistering skin diseases among others. New biologics and phosphodiesterase inhibitors for psoriasis and atopic dermatitis, JAK inhibitors for alopecia areata and vitiligo, immune checkpoint inhibitors for melanoma and rituximab for pemphigus are all covered. - Features a revised and revamped cutaneous adverse drug reaction section, including novel eruptions from new and emerging chemotherapeutic agents and small molecule/targeted inhibitors. - Discusses new and emerging viruses including Zika and human polyomaviruses.

Due to the increasing exposure of the skin to damaging environmental influences such as ultraviolet radiation, climatic determinants, chemicals or infections, research in this field is rapidly progressing. The interaction between the skin and the environment presents a fascinating and challenging research subject. For instance, skin aging and skin carcinogenesis are caused by both genetic and environmental factors. And also in diseases like psoriasis, atopic dermatitis and collagen diseases, genetic, immunologic and environmental factors interact. In recent years, new technologies to investigate skin response have allowed researchers to explore the interplay of environmental and genomic elements in skin cell biology, decipher the biochemical steps undertaken in the process, and study the genetics underlying variations in skin response to the environment. In this volume the state-of-the-art findings, ranging from molecular biology to epidemiology, are discussed thoroughly. The publication thus provides new insights for dermatologists, allergologists and immunologists who seek a better understanding of disease processes and new therapeutic strategies.

As the number of surviving immune suppressed patients continues its rapid increase, the skin manifestations have become increasingly important. AIDS patients and renal, heart, liver, bone marrow and lung transplant patients are surviving longer and are often experiencing skin side effects of immunity suppression. Diabetes is exploding in the USA and offers its own unique brand of immune suppressed skin diseases. Immunosuppressive drugs are being used more frequently and newer biologics and tyrosine kinase drugs have added to new categories of immune suppressed patients. This book aims to clearly elucidate the signs of immune suppressed skin disease to afford early diagnosis and management of this ever-increasing, diverse group of illnesses.